Evidence map›Paper›PMID 39487159›Full record

ArticleNPJ primary care respiratory medicine2024

Over-the-counter short-acting β

David Price, Maarten J H I Beekman, Walter Javier Mattarucco, Rocio Martina Barriga-Acevedo, Hao-Chien Wang, Dina V Diaz, Adel Khattab, Manuel Pacheco Gallego, Ashraf Al Zaabi, Hisham Farouk and 1 more

Abstract read
In one paragraph

Article in NPJ primary care respiratory medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David PriceCentre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
Maarten J H I BeekmanRespiratory & Immunology, AstraZeneca, The Hague, The Netherlands. medicalimpactplus@gmail.com.
Walter Javier MattaruccoNeumonólogo, CEPROSS (Centro Profesional San Salvador), Entre Rios, Argentina.
Rocio Martina Barriga-AcevedoHospital Angeles Chihuahua, Chihuahua, Mexico.
Hao-Chien WangDepartment of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.
Dina V DiazLung Center of the Philippines, Manila, Philippines.
Adel KhattabPulmonary Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Manuel Pacheco GallegoUnversidad Tecnológica de Pereira Y Fundación Universitaria Visión de las Américas, Respiremos S.A.S- Salud Clinica Comfamiliar, Pereira, Risaralda, Colombia.
Ashraf Al ZaabiInternal Medicine Department, College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi, United Arab Emirates.
Hisham FaroukRespiratory & Immunology, AstraZeneca, Dubai, United Arab Emirates.
Darush Attar-ZadehNorth West London Integrated Care Board, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This post-hoc analysis of the SABINA III study evaluated the association of short-acting β

Indexed as

Adrenergic beta-2 Receptor AgonistsAsthmaNonprescription DrugsAdultAnti-Asthmatic AgentsFemaleHumansMaleMiddle AgedSeverity of Illness IndexAdrenergic beta-2 Receptor AgonistsAnti-Asthmatic AgentsNonprescription Drugs

Identifiers

PMID39487159
PMCPMC11530521

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.